ProtectLife International Biomedical was honored to be received by the President at the Presidential Office today (Oct 1) alongside fellow "2026 Taiwan BIO Awards" winners, recognizing its excellence in biomedical innovation.
The company earned the Product Innovation Award for its self-developed ENNOLIFE Clinical Chemistry Analyzer and Series, a platform designed for micro-sample blood testing and Point-of-Care (POCT) applications.
As a Taiwan-based R&D manufacturer of In Vitro Diagnostics (IVD) and POCT equipment, ProtectLife focuses on addressing diverse clinical and testing needs through proprietary technologies, rigorous quality management, and product optimization.
This recognition marks a major milestone for the team. Moving forward, ProtectLife will continue to advance smart diagnostics, strengthen core technologies, and leverage its Taiwan R&D foundation to expand its global footprint under the brand vision of "Protecting Life."
